Safety and efficacy of direct oral anticoagulants across body mass index groups in patients with venous thromboembolism: a retrospective cohort design
RM Cardinal, F D'Amico, A D'Addezio, K Dakers… - Journal of Thrombosis …, 2021 - Springer
Current literature on the safety and efficacy of direct oral anticoagulants (DOACs) in patients
of extreme weights are limited, however, they are still being prescribed in these populations …
of extreme weights are limited, however, they are still being prescribed in these populations …
Anticoagulation treatment and outcomes of venous thromboembolism by weight and body mass index: insights from the veterans health administration
AC Perino, J Fan, S Schmitt, JD Guo… - … Quality and Outcomes, 2021 - Am Heart Assoc
Background: Consensus statements have recommended against the use of direct oral
anticoagulants (DOACs) in venous thromboembolism (VTE) for patients≥ 120 kg and≥ 40 …
anticoagulants (DOACs) in venous thromboembolism (VTE) for patients≥ 120 kg and≥ 40 …
Direct oral anticoagulants in obese patients with venous thromboembolism: results of an expert consensus panel
RP Rosovsky, E Kline-Rogers, L Lake… - The American journal of …, 2023 - Elsevier
In clinical practice, direct oral anticoagulants (DOACs) are increasingly used for venous
thromboembolism treatment and prevention. A substantial proportion of patients with venous …
thromboembolism treatment and prevention. A substantial proportion of patients with venous …
Real life results of direct-acting oral anticoagulants recommended-dose in obese vs normal-weight patients with venous thromboembolism
JA Rueda-Camino, R Barba, S Otálora… - Thrombosis …, 2024 - Elsevier
Background There is scarce evidence on the effectiveness and safety of recommended-
dose direct acting oral anticoagulants (DOACs) in obese patients with venous …
dose direct acting oral anticoagulants (DOACs) in obese patients with venous …
Direct oral anticoagulants in the treatment of acute venous thromboembolism in patients with obesity: a systematic review with meta-analysis
V Mai, E Marceau-Ferron, L Bertoletti, Y Lacasse… - Pharmacological …, 2021 - Elsevier
Background Direct oral anticoagulants'(DOAC) pharmacokinetics are affected by obesity.
Their efficacy and safety in obesity (BMI≥ 30 kg/m 2) and morbid obesity (BMI≥ 40 kg/m 2) …
Their efficacy and safety in obesity (BMI≥ 30 kg/m 2) and morbid obesity (BMI≥ 40 kg/m 2) …
[HTML][HTML] The use of direct oral anticoagulants in the management of venous thromboembolism in patients with obesity
M Younis, A Elkaryoni, GW Williams, I Jakhar, S Suman… - Cureus, 2020 - ncbi.nlm.nih.gov
Methods We utilized the Health Facts Center National Data Warehouse (Cerner) to perform
a retrospective analysis of patients with VTE (acute deep venous thrombosis (DVT) or …
a retrospective analysis of patients with VTE (acute deep venous thrombosis (DVT) or …
Efficacy and safety of direct oral anticoagulants in obese patients with venous thromboembolism
RA Sa, F Al-Ani, A Lazo-Langner, ML Louzada - Blood, 2019 - Elsevier
Background: Obesity is a well-known risk factor for venous thromboembolism (VTE),
however, obese patients are under-represented in clinical trials (1; 2). Four direct oral …
however, obese patients are under-represented in clinical trials (1; 2). Four direct oral …
[HTML][HTML] Efficacy and safety of direct oral anticoagulants in venous thromboembolism compared to traditional anticoagulants in morbidly obese patients: a systematic …
Background Randomized clinical trials comparing the efficacy and safety of direct oral
anticoagulants (DOAC) with vitamin K antagonist (VKA) or low molecular weight heparin …
anticoagulants (DOAC) with vitamin K antagonist (VKA) or low molecular weight heparin …
Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic …
MN Elshafei, MFH Mohamed, A El-Bardissy… - Journal of thrombosis …, 2021 - Springer
Direct oral anticoagulant (DOAC) agents are becoming the anticoagulation strategy of
choice. However, their use in the treatment of acute venous thromboembolism (VTE) in …
choice. However, their use in the treatment of acute venous thromboembolism (VTE) in …
Anticoagulant therapies and outcomes in obese patients with acute venous thromboembolism
S Quan, J Smith, C Wu, SL Koshman, B Nguyen… - Thrombosis …, 2020 - Elsevier
Abstract Background Direct oral anticoagulants (DOACs) are recommended in preference to
traditional anticoagulants (LMWH±warfarin) for treating acute venous thromboembolism …
traditional anticoagulants (LMWH±warfarin) for treating acute venous thromboembolism …
相关搜索
- efficacy and safety venous thromboembolism
- obese patients venous thromboembolism
- cohort design venous thromboembolism
- cohort design safety and efficacy
- oral anticoagulants venous thromboembolism
- body mass venous thromboembolism
- efficacy and safety traditional anticoagulants
- body mass anticoagulation treatment
- efficacy and safety obese patients
- obese patients anticoagulant therapies
- consensus panel venous thromboembolism
- meta analysis venous thromboembolism
- efficacy and safety meta analysis
- traditional anticoagulants venous thromboembolism
- obese patients effectiveness and safety
- anticoagulation treatment venous thromboembolism